tiprankstipranks
Lantern Pharma, Inc. (LTRN)
NASDAQ:LTRN
US Market

Lantern Pharma (LTRN) Technical Analysis

211 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Lantern Pharma, Inc.’s (LTRN) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Lantern Pharma, Inc. is a Sell.
Lantern Pharma, Inc.’s (LTRN) 20-Day exponential moving average is 6.21, while Lantern Pharma, Inc.’s (LTRN) share price is $6.01, making it a Sell.
Lantern Pharma, Inc.’s (LTRN) 50-Day exponential moving average is 6.26, while Lantern Pharma, Inc.’s (LTRN) share price is $6.01, making it a Sell.

Lantern Pharma (LTRN) Pivot Points

May 30, 2024, 03:25 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.37
5.76
6.02
6.41
6.66
7.05
7.31
Fibonacci
5.76
6.01
6.16
6.41
6.65
6.80
7.05
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lantern Pharma (LTRN) Moving Averages

May 30, 2024, 03:25 AM
Period
Simple
Exponential
MA5
6.28Sell
6.22Sell
MA10
6.19Sell
6.21Sell
MA20
6.14Buy
6.21Sell
MA50
6.96Sell
6.26Sell
MA100
5.81Buy
5.91Buy
MA200
4.81Buy
5.30Buy
Lantern Pharma, Inc.’s (LTRN) 10-Day exponential moving average is 6.21, while Lantern Pharma, Inc.’s (LTRN) share price is $6.01, making it a Sell.
Lantern Pharma, Inc.’s (LTRN) 100-Day exponential moving average is 5.91, while Lantern Pharma, Inc.’s (LTRN) share price is $6.01, making it a Buy.
Lantern Pharma, Inc.’s (LTRN) stock price is $6.01 and Lantern Pharma, Inc.’s (LTRN) 50-day simple moving average is 6.96, creating a Sell signal.
Lantern Pharma, Inc.’s (LTRN) stock price is $6.01 and Lantern Pharma, Inc.’s (LTRN) 100-day simple moving average is 5.81, creating a Buy signal.
Lantern Pharma, Inc.’s (LTRN) stock price is $6.01 and Lantern Pharma, Inc.’s (LTRN) 200-day simple moving average is 4.81, creating a Buy signal.

Lantern Pharma (LTRN) Technical Indicators

May 30, 2024, 03:25 AM
Name
Value
Implied Action
RSI (14)
49.01
Neutral
STOCH (9,6)
55.47
Neutral
STOCHRSI (14)
42.10
Neutral
MACD (12,26)
-0.04
Sell
ADX (14)
13.75
Buy
Williams %R
-59.29
Buy
CCI (14)
31.41
Neutral
ATR (14)
0.62
-
Ultimate Oscillator
42.96
Neutral
ROC
-3.74
Sell
Lantern Pharma, Inc.’s (LTRN) Relative Strength Index (RSI) is 49.01, creating a Neutral signal.
Lantern Pharma, Inc.’s (LTRN) Trend Strength Indicator (ADX) is 13.75, creating a Buy signal.
Lantern Pharma, Inc.’s (LTRN) Commodity Channel Index (CCI) is 31.41, creating a Neutral signal.
Lantern Pharma, Inc.’s (LTRN) Price Rate of Change (ROC) is -3.74, creating a Sell signal.

FAQ

Is LTRN a Buy, Hold, or Sell?
Based on LTRN’s technical indicators, LTRN is a Hold.
    What is LTRN’s RSI (14)?
    LTRN’s RSI (14) is 49.01, which suggests LTRN is a Neutral.
      What is LTRN’s MACD?
      LTRN’s MACD is -0.04, which suggests LTRN is a Sell.
        What is LTRN’s 5-day moving average?
        LTRN’s 5-day moving average is 6.28, which suggests LTRN is a Sell.
          What is LTRN’s 20-day moving average?
          LTRN 20-day moving average is 6.14, which suggests LTRN is a Buy.
            What is LTRN’s 50-day moving average?
            LTRN’s 50-day moving average is 6.96, which suggests LTRN is a Sell.
              What is LTRN’s 200-day moving average?
              LTRN’s 200-day moving average is 4.81, which suggests LTRN is a Buy.
                What is LTRN’s Williams % R (14)?
                LTRN’s Williams % R (14) is -59.29, which suggests LTRN is a Buy.
                  What is LTRN’s CCI (14)?
                  LTRN’s CCI (14) is 31.41, which suggests LTRN is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis